TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 2 | 6 | -4 | 2 | 29 | 14 | 46 | 16 |
S | %wins | 0 | 100 | 50 | 0 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/14 16:30 | 4/30/14 | SYN | Synthetic Biologics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Kanzer Steve H | FL | TH | Prior Di | S | -7,154 | 1.43 | 5 | -5,003 | -70 | 2,195 | I | -19 | -1 | -3 | -24 | -58 | -42 | -52 | -51 | 9 | -2 | 6 | 31 | 19 | 55 |
4/30/14 17:01 | 4/28/14 | SYN | Synthetic Biologics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Kanzer Steve H | FL | TH | Prior Di | S.dm | -763 | 2.90 | 4 | -263 | -4 | 7,199 | I | 23 | 37 | 31 | 21 | -33 | -9 | -17 | -32 | 3 | -5 | -2 | 27 | 9 | 37 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |